3 completed, 1 terminated, 1 withdrawn. 3 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 1, Terminated 1, Withdrawn 1 |
| Phase 2 | 2 | Completed 2 |
Follow ibodutant: new trials by email Literature Review of ibodutant trials Research Report on ibodutant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D) Ibodutant 10 mg, Placebo - Irritable Bowel Syndrome With Diarrhea | Phase 3 | Withdrawn | Menarini Group | 2015-10-01 | 2016-05-19 | |
| 12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D) Ibodutant 10 mg, Placebo - Irritable Bowel Syndrome With Diarrhea | Phase 3 | Completed | Menarini Group | 535 | 2014-03-01 | 2017-01-19 |
| 52-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D) Ibodutant 10 mg, Placebo - Irritable Bowel Syndrome With Diarrhea | Phase 3 | Terminated | Menarini Group | 558 | 2014-02-01 | 2017-03-03 |
| Ibodutant for Relief of Irritable Bowel Syndrome With Diarrhoea (IBS-D) Ibodutant, Placebo - Irritable Bowel Syndrome With Diarrhea | Phase 2 | Completed | Menarini Group | 565 | 2010-10-01 | 2015-10-07 |
| Ibodutant for Relief of Irritable Bowel Syndrome (IRIS) Ibodutant, Placebo - Irritable Bowel Syndrome | Phase 2 | Completed | Menarini Group | 554 | 2008-07-01 | 2012-03-21 |
Intestinal Diseases (5) · Irritable Bowel Syndrome (5) · Diarrhea (3)
Menarini Group (5)
Germany (4) · Czechia (3) · Poland (3) · United Kingdom (3) · Bulgaria (2) · Denmark (2) · Italy (2) · Latvia (2) · Russia (2) · Spain (2) · Sweden (2) · United States (2) · France (1) · Hungary (1) · Romania (1)
Jan Tack, Professor (3) · Lin Chang, Professor (2) · Jan F Tack, Prof. (1) · Jan F Tack, Professor (1)
2008 (1)